Huma Therapeutics closes $80M in a Series D funding round led by AstraZeneca, Hitachi Ventures, and Bayer to launch a 'Shopify-like' AI digital health platform
Huma Therapeutics closes $80M in a Series D funding round led by AstraZeneca, Hitachi Ventures, and Bayer to launch a 'Shopify-like' AI digital health platform
07/16/24, 11:14 AM
Location
londonMoney raised
$80 million
Industry
medical
artificial intelligence
biotechnology
health care
Round Type
series d
Investors
Leaps By Bayer, Hv Fund By Hitachi Ventures, Hat Technology Fund 4, Astra Zeneca
Huma Therapeutics has closed a $80M Series D funding round, bringing the total funding raised to $300 million. The round saw participation from AstraZeneca, Hat Technology Fund 4, HV Fund by Hitachi Ventures, Leaps by Bayer, and others. In addition, the company has launched Huma Cloud Platform, a GenAI-powered 'Shopify-like' experience for the digital health ecosystem.
Company Info
Location
london, england, united kingdom
Additional Info
Huma Therapeutics is a healthcare AI company focused on accelerating the adoption of digital solutions in care and research. Their technology powers multi-channel patient engagement at population-wide scale for healthcare systems, remote patient monitoring (RPM) at scale, companion apps to support patients through treatment and drug therapies, and digital clinical trials to accelerate medical research.